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ABSTRACT
Soxproteinsarewidelybelievedtoteamupwithother
transcription factors as partner proteins to perform
their many essential functions during development.
In this study, yeast two-hybrid screens identified
transcription factors as a major group of interacting
proteinsforSox8andSox10.Interactingtranscription
factors were very similar for these two group E Sox
proteins and included proteins with different types
of DNA-binding domains, such as homeodomain
proteins, zinc finger proteins, basic helix–loop–helix
and leucine zipper proteins. In all cases analyzed,
the interaction involved the DNA-binding domain of
the transcription factor which directly contacted the
C-terminal part of the high-mobility-group (HMG)
domain. In particular, the C-terminal tail region
behind helix 3 of the HMG domain was shown by
mutagenesistobeessentialforinteraction and trans-
criptionfactorrecruitment.TheHMGdomainthusnot
only possesses DNA-binding and DNA-bending but
also protein-interacting ability which may be equally
important for the architectural function of Sox
proteins on their target gene promoters.
INTRODUCTION
Soxproteinsare importanttranscriptionalregulatorsofvarious
developmental processes (1,2). Compared to other transcrip-
tion factors, Sox proteins are unusual in that they introduce
a strong bend into DNA upon binding to the minor groove.
Sox proteins therefore alter DNA conformation and act as
architectural proteins. A second characteristic feature of all
Sox proteins is their dependence on other transcription factors
as partner proteins for efﬁcient target gene activation (3,4).
The 20 different Sox proteins that exist in mammals can be
classiﬁed into several groups according to sequence simi-
larities (5). Group E Sox proteins (also referred to as SoxE
proteins) include Sox8, Sox9 and Sox10 in mammals. They
exhibit partially overlapping expression patterns during
embryogenesis and when co-expressed often exert similar
functions arguing for at least partial functional redundancy
among them (6–8). However, there are also developmental
processes in which SoxE proteins have unique roles. Sox9,
for example, is speciﬁcally required for chondrogenesis,
whereas Sox10 alone drives gliogenesis in the peripheral
nervous system (9,10).
It is astonishing that all three SoxE proteins control seem-
ingly unrelated developmental processes in different tissues
and can regulate consecutive steps during cell lineage progres-
sion (10–12). The pleiotropic actions of Sox proteins are
usually attributed to their reliance on partner proteins. Accord-
ing to this model, Sox proteins acquire a function based on the
transcription factors co-expressed in a particular tissue and
change function with each shift in trancription factor patterns
during cell lineage progression.
Only few of these partner proteins have so far been
identiﬁed for SoxE proteins (13–19). Here we show that the
high-mobility-group (HMG) domain of SoxE proteins estab-
lishes weak interactions with DNA-binding domains of
numerous transcription factors in solution. These weak inter-
actions may be the basis for the establishment of cooperati-
vity between Sox proteins and their partners on target gene
promoters and for the resulting synergistic gene activation.
MATERIALS AND METHODS
Plasmid constructs
To generate bait plasmids for yeast two-hybrid screening,
fragments of the rat Sox10 cDNA (GenBank accession
no. AJ001029) were generated by PCR that code for amino
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doi:10.1093/nar/gkl105acids 1–230 or amino acids 133–203. These fragments were
inserted into pGBKT7 (Clontech) using EcoRI and BamHI
restriction sites. A fragment corresponding to amino acids
124–192 of mouse Sox8 (GenBank accession no.
NM_011447) was analogously inserted into the pGBKT7
bait plasmid. Coding sequences from potential interaction
partners identiﬁed in the yeast two-hybrid screen were
retrieved from the pVP16 prey plasmid and cloned in frame
behind a T7 epitope tag into the eukaryotic expression vectors
pcDNA3 or pCMV5 using XhoI in combination with EcoRI
or HindIII restriction sites. DNA-binding domains of
additional transcription factors were obtained by PCR and
similarly inserted behind a T7 epitope tag into eukaryotic
expression vectors. The following primers were used: 50-
AGATCCCGGTGCAG-30 and 50-CCCACTGTTAACGTG-
GTTC-30 for c-Jun (accession no. X17163), 50-CGGTGGA-
TAAGAACAGCAAC-30 and 50-GCTCTCAGGCAGCTGG-
30 for C/EBPa (accession no. NM_012524), 50-AGGA-
AAGGCGGATGG-30 and 50-TTCTAGACTAAGGAT-
GACTGC-30 for REB (accession no. NM_013176),
50-AGCTGCGCCTGAAGATCAAC-30 and 50-GGTGAG-
CATGAGGATGTAGTTTC-30 for Olig2 (accession no.
AB038697), 50-CGTACCCCTGCCCAG-30 and 50-GTGGA-
TCTTGGTGTGGCG-30 for Krox-20 (accession no. U78102),
50-AGCATATTTGCCACATCCAAG-30 and 50-GTGGGTC-
TTGATATGTTTTGA-30 for Sp1 (accession no. J03133),
50-CTCGCTACTGTGCAGT-30 and 50-GTCTTTTCGT-
ATCCCACC-30 for estrogen receptor (accession no.
NM_000125), 50-ACGAGCTCTGTGTAGTG-30 and 50-GT-
CATCCAGCACCAAATC-30 for thyroid hormone receptor
b (accession no. NM_000461), 50-CCGAGGAGTCCCAGG-
30 and 50-TGTCGGCTTCCTCCACC-30 for the POU-speciﬁc
domain of Oct-3/4 (accession no. NM_013633) and 50-TCGG-
CCAGGGCCG-30 and 50-CCTCAGGATGCGACTGATGG-
AAC-30 for the paired domain of Pax3 (accession no.
XM_343601). Coding sequences for Sox8 (amino acids
1–175) and Sox10 (amino acids 1–203), were placed in
frame behind a myc epitope tag in pCMV5-based expression
plasmids (20). pCMV-Sox10, pCMV-Sox8 and pCMV-
Brn2 have been described previously (21–23). Luciferase
reporter plasmids carried a multimerized AP1 response
element (TRE-luc) or the Schwann cell speciﬁc enhancer
of the mouse Krox-20 gene (SCE-luc) (15) in front of the
TATA-box containing minimal b-globin promoter (23).
Bacterial expression plasmids for glutathione-S-transferase
(GST) fusion proteins were created by placing PCR fragments
corresponding to amino acids 17–147 or 133–203 of rat Sox10
(Sox10 A and Sox10 B), amino acids 96–124 or 122–175 of
mouse Sox8 (Sox8 A and Sox8 B) as well as amino acids
58–84 or 84–133 of human SRY (SRY A and SRY B) in
frame behind the GST coding sequence into pGEX-KG.
Amino acid substitutions were introduced into the Sox10
sequences of pGEX-KG-Sox10 B using the QuickChange
mutagenesis Kit (Stratagene) to generate mutants m1
(R176E) and m2 (R161E, K165E). GST fusions were also
generated with the HMG domain of mouse LEF-1 (amino
acids 297–365 according to accession no. NM_010703), the
second HMG domain of mouse HMGB1 (amino acids 94–162,
according to accession no. Z11997), and with the third and
sixth HMG domains of mouse UBF1 (amino acids 298–362
and 568–634 according to accession no. X60831).
Yeast two-hybrid screen
A pVP16-based cDNA-library prepared from 10.5 days
post coitum (dpc)-old mouse embryos where preys are
expressed as fusions with the VP16-transactivation domain
(24) was introduced by transformation into yeasts (strain
AH109) that already carried pGBKT7-based plasmids and
expressed the N-terminal region of Sox10 (amino acids
1–230) or the C-terminal part of the HMG domain of Sox8
(amino acids 124–192) or Sox10 (amino acids 133–203) as
baits in frame with the Gal4-DNA-binding domain. In total,
8 · 10
5 independent colonies were screened with Sox10
(amino acids 1–230), 1 · 10
6 colonies with Sox10 (amino
acids 133–203) and 3 · 10
6 colonies with Sox8 (amino
acids 124–192). Transformants were plated on medium lack-
ing tryptophane, leucine and histidine. Growth was evaluated
after ﬁve days of incubation at 30 C. Yeast colonies were
further analyzed by ﬁlter-lift assays for b-galactosidase
reporter activity. Prey plasmids were retrieved from b-galac-
tosidase-positive colonies and retransformed with the bait
to verify the interaction. Nineteen percent of veriﬁed preys
correspondedtotranscriptionfactorsand27%tootherproteins
with nuclear localization. Thirty-three percent were predomi-
nantly localized outside the nucleus and the remaining
21% were proteins of unknown function and subcellular
localization.
Cell culture, transfections, extract preparations and
luciferase assays
HEK 293 and S16 cells were kept in DMEM supplemented
with 10% (v/v) fetal calf serum (FCS). For the production of
Sox proteins and DNA-binding domains of various transcrip-
tion factors, HEK 293 cells were transiently transfected by
the calcium phosphate technique using 10 mg plasmid DNA
per 100 mm plate. After 48 h post transfection, cells were
harvested for extract preparation. Brieﬂy, whole cell extracts
from HEK 293 cells were prepared using 2 mg leupeptin and
aprotinin each in ice cold 20 mM HEPES (pH 7.9), 10 mM
KCl, 5 mM MgCl2, 0.5 mM EDTA, 10% glycerol, 2 mM DTT,
0.1% Triton X-100 and 300 mM NaCl. After extraction for
15 min under constant rotation, cell debris was removed from
the extract by centrifugation (25). For luciferase assays, S16
cells were transfected in 35 mm plates using Superfect
reagent (Qiagen) with 0.5 mg of luciferase reporter plasmid
and 0.5 mg of pCMV5 effector plasmid, if not stated otherwise.
Cells were harvested and reporter gene expression was
analyzed 48 h post transfection (25).
GST pulldowns, co-immunoprecipitations and
western blotting
For pulldown experiments, GST or GST fusion proteins with
parts of Sox8, Sox10, SRY, LEF-1, UBF1 and HMGB1 were
produced in Escherichia coli strain BL21 DE3 pLysS and
bound in the presence of DNase I to glutathione Sepharose
4B beads as described (26). An aliquot of the washed and
equilibrated beads, now carrying GST or the GST fusion
protein, was incubated with one-tenth of the HEK 293 extract
obtained from a 100 mm plate in interaction buffer [20 mM
HEPES (pH 7.9), 10 mM KCl, 5 mM MgCl2, 0.5 mM EDTA,
5% glycerol, 1 mM DTT, 0.05% Triton X-100 and 100 mM
NaCl]. After centrifugation and washing, bead-bound proteins
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transferred to a nitrocellulose membrane.
For co-immunoprecipitation, one-seventh of the extract
obtained from one 100 mm plate was incubated for 2 h at
4 C in 300 ml interaction buffer with mouse monoclonal
anti-myc-antibodies (clone 9E10, hybridoma supernatant)
already coupled to 30 ml of protein A-Sepharose CL-4B
beads (Amersham Biosciences). After centrifugation, the
beads were washed, before precipitated proteins were
separated by SDS–PAGE and transferred to a nitrocellulose
membrane.
Western blotting was performed as described (27) using a
mouse monoclonal antibody against the T7 epitope tag
(1:10 000 dilution, Novagen) or a rabbit antiserum against
Sox10 (1:3000 dilution) (21) as primary antibodies, and horse-
radish peroxidase (HRP) coupled goat-anti-mouse antibodies
or HRP coupled protein A as secondary detection reagents
with enhanced chemiluminescence.
RESULTS
Many transcription factors interact via their
DNA-binding domain with Sox10 and Sox8 in yeast
two-hybrid screens
To identify interaction partners for the HMG domain of SoxE
proteins, we performed yeast two-hybrid screens with the
N-terminal region of Sox10 (Figure 1a). This bait includes
the HMG domain as well as the DNA-dependent dimerization
domain that is speciﬁc to SoxE proteins (25,28). Using a
library prepared from mouse 10.5 dpc-old embryos, we iden-
tiﬁed several transcription factors including the homeodomain
proteins Meox1 and Pax6 and the zinc-ﬁnger protein Hivep1
(Figure 1b). In all cases, the identiﬁed region of the interacting
protein contained at least part of the homeodomain or several
zinc ﬁngers indicating that the DNA-binding domain mediates
the interaction with SoxE proteins.
To extend our screen and simultaneously analyze whether
interaction is primarily mediated by the HMG domain or
rather by the protein region preceding the HMG domain,
we repeated the yeast two-hybrid screen with a shorter bait
from the HMG domain. The region chosen for this screen
consisted of amino acids 133–203 and contained helices
2 and 3 and the C-terminal tail of the Sox10 HMG domain
(Figure 1a). Helix 3 and the C-terminal tail are still solvent
exposed when the HMG domain binds to DNA and should
therefore be accessible to interacting proteins (29,30). Using
this bait, we again identiﬁed interactions with several home-
odomain proteins. Identiﬁed interactors include Dlx5, Hhex,
Alx4, Hoxa3 and Brn-1 (Figure 1b). The interacting region
again contained at least part of the homeodomain. In case
of Brn-1, both the homeodomain and a small part of the
POU-speciﬁc domain were present in the interacting region,
which is furthermore almost completely conserved in
the related Brn-2 and Oct-6 proteins. Our ability to
detect homeodomain-containing interactors both with the
HMG-speciﬁc bait and with the complete N-terminal region
is compatible with the conclusion that on the side of the Sox
protein, the HMG domain is involved in the interaction. As the
identiﬁed homeodomain proteins belong to diverse groups
of the homeodomain superfamily, the interaction between
homeodomain and HMG domain appears to be a general
feature. Additionally, we isolated a region from UTF1 that
corresponded to its bHLH domain (Figure 1c), indicating that
the range of interactors might extend to members of the bHLH
family of transcription factors.
Figure 1. Interaction of SoxE proteins with other transcription factors.
(a) Schematic representation of Sox10 and Sox8 with their HMG domain
and delineation of the regions used as bait in yeast two-hybrid screens.
Numbers above bars or lines represent amino acids at the beginning or end
of proteins, protein domains and baits. (b–d) Summary of transcription factors
identifiedinyeasttwo-hybridscreenswithaSox10baitcontainingaminoacids
1–230 (b), a Sox10 bait containing amino acids 133–203 (c) and a Sox8
bait containing amino acids 124–192 (d). In addition to transcription factor
names, accession numbers and obtained amino acid residues are listed as well
as the domain identified in the screen.
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that corresponds to the C-terminal region of the HMG domain
of Sox8 including helix 2, helix 3 and the C-terminal tail
(amino acids 124–192, Figure 1a), we also obtained several
homeodomain proteins. Speciﬁcally, Prrx1, Prrx2 and Hoxc4
were identiﬁed with at least part of their homeodomain pre-
sent in the preys (Figure 1d). The HMG domains of the two
related SoxE proteins Sox8 and Sox10 thus interact with at
least similar sets of transcription factors. Whether interacting
transcription factors are only similar or even identical, cannot
be concluded from our yeast two-hybrid screens because the
number of screened yeast colonies was too low to achieve
complete coverage of the cDNA library.
In addition to transcription factors, many other proteins
were identiﬁed as potential interaction partners in our screen
(see Materials and Methods), including subunits of chromatin
remodelling complexes, chromatin modiﬁers, transcriptional
cofactors, protein kinases and in accord with recent studies
(31,32) components of the sumoylation system.
Interaction with SoxE proteins is mediated through
the C-terminal part of the HMG domain
To conﬁrm the interactions, we performed GST-pulldown
experiments for a selected set of candidates representing the
different transcription factor families from which members
were identifed in the yeast two-hybrid screens. GST fusion
proteins were used that either contained N-terminal Sox10
regions including the front part of the HMG domain up to
helix 2 (Sox10 A in Figure 2a), or the hind part of the
HMG domain with helices 2 and 3 and the C-terminal tail
(Sox10 B in Figure 2a). In agreement with the results from
yeast two-hybrid screens, all homeodomain proteins tested in
GST pulldown experiments, including Dlx5, Hhex and Brn-1,
interacted speciﬁcally with the GST fusion carrying the
C-terminal part of the Sox10 HMG domain, not however
with GST alone or the GST fusion carrying the N-terminal
part of the HMG domain and preceding amino acid sequences
(Figure 2b). The bHLH protein UTF1 also interacted specif-
ically with the C-terminal part of the Sox10 HMG domain
(Figure 2b). In general, GST pulldown experiments involving
DNA binding proteins are prone to artefacts, as binding of
both proteins to contaminating DNA is difﬁcult to distinguish
from bona ﬁde protein–protein interactions. However, most of
our GST pulldown experiments were carried out with
GST–Sox10fusionproteinsthatlacked anintactHMGdomain
and thus were unable to bind to DNA. Results were further-
more identical when DNase I was continuously present
throughout the experiment (data not shown and Figure 4b),
indicating that pulldowns indeed reﬂect true protein–protein
interactions.
We also included GST fusion proteins in our pulldown
experiments that carried parts of the HMG domain of Sox8
and the more distantly related SRY. Interestingly, all candi-
dates that interacted with the C-terminal part of the Sox10
HMG domain also interacted speciﬁcally with the correspond-
ing region of Sox8 and SRY (Figure 2b), thus indicating that
the interactors identiﬁed in our screen are probably common
interactors for all Sox proteins. In contrast, no interaction was
Figure 2. Confirmation of yeast two-hybrid interactions in GST
pulldown experiments. (a) Schematic representation of Sox10, Sox8 and
SRY with their HMG domain and GST fusion proteins GST-Sox10A,
GST-Sox10B, GST-Sox8A, GST-Sox8B, GST-SRYA and GST-SRYB.
Numbers above bars represent amino acids at the beginning or end of proteins,
domains and protein fragments. (b) Regions from several transcription
factorsidentifiedintheyeasttwo-hybridscreen(Dlx5,Hhex,UTF1andBrn-1)
were tagged with a T7 epitope, expressed in HEK 293 cells and analyzed for
their ability to interact with GST or the GST-Sox10A, GST-Sox10B,
GST-Sox8A, GST-Sox8B, GST-SRYA and GST-SRYB fusions. The amount
of each transcription factor present in one-tenth of the extract before
pulldown (1/10 input) is shown in the right lane of each panel.
Transcription factor regions were detected on western blots via their T7
epitope tag.
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Sox8 and SRY.
Next we investigated whether the Sox HMG domain
also interacted with other transcription factors with which
Sox proteins are known to be co-expressed in various cell
types during different phases of development. These trans-
cription factors covered a broad spectrum of different
DNA-binding domains. With Olig2 and REB, two additional
bHLH proteins were tested that are co-expressed with Sox10
and Sox8 in oligodendrocytes and with Sox10 in Schwann
cells, respectively (33–35). Both interacted with the HMG
domains of Sox10, Sox8 and SRY in a manner similar to
UTF1 (Figure 3). We also included bZip proteins in our
study. Although no bZip transcription factor was originally
obtained in our yeast two-hybrid screen, both c-Jun and
C/EBPa interacted with the HMG domain of Sox10. Again
this interaction occurred speciﬁcally with the C-terminal
region of the HMG domain. It was similarly observed with
the HMG domains of Sox8 and SRY. Among zinc ﬁnger
proteins, both Krox-20 and Sp1 interacted with the HMG
domain of Sox10, Sox8 and SRY. These interactions may
also be relevant under physiological conditions as Krox-20
is co-expressed with Sox10 in myelinating Schwann cells,
whereas Sp1 has been proposed to support Sox10 in its
activation of the myelin gene MBP in oligodendrocytes
(36,37). Among the tested zinc ﬁnger proteins, there were
also two nuclear receptor proteins. These were the estrogen
receptor and the thyroid hormone receptor b (Figure 3). Both
reproducibly failed to interact via their DNA-binding
domain with the HMG domain of Sox10, Sox8 or SRY.
These results do not exclude the possibility that these
nuclear receptors might establish contacts with Sox proteins
either through different regions outside the DNA-binding
domain or through one of the many co-factors for nuclear
receptors.
In our original yeast two-hybrid screen, a Pax protein
and a POU protein were identiﬁed. As evident from the
preys, the interaction with the HMG domain was likely medi-
ated in both cases by the homeodomain. In addition to the
homeodomain, these proteins possess a second DNA-binding
domain which in case of the Pax protein is a paired domain
and in case of the POU protein is a POU-speciﬁc domain. To
analyze whether these DNA binding domains also possess
the capability to interact with the HMG domain of Sox10,
we performed GST pulldown assays with the paired domain
of Pax3 and the POU-speciﬁc domain of Oct-3/4. In both
cases interaction was detected with the C-terminal part of
the Sox HMG domain (Figure 3).
HMG domains are not only present in Sox proteins, but
also in other sequence-speciﬁc and non-sequence-speciﬁc
DNA-binding proteins. We therefore tested HMG domains
from LEF-1, HMGB1 and UBF1 (Figure 4a) in GST pulldown
experiments for their ability to interact with a representative
set of DNA-binding domains. In contrast to the HMG domain
of Sox10, none of these HMG domains exhibited signiﬁcant
binding to the bHLH region of Olig2, the bZip region of
C/EBPa, the Krox-20 zinc ﬁngers, the paired domain of
Pax3 or the homeodomain of Dlx5 (Figure 4b). We therefore
conclude that the interactions are speciﬁcfor the HMG domain
of Sox proteins.
Interaction with the HMG domain of SoxE proteins
is weak
As most of our GST pulldown studies were performed with
GST fusions carrying HMG domain fragments that may not
fold properly, we tried to reproduce the interaction by co-
immunoprecipitation from extracts of transfected HEK293
cells that contained a SoxE protein with intact HMG domain.
In these experiments SoxE proteins carried an N-terminal
myc-tag which was used for immunoprecipitation. Detection
of the co-immunoprecipitated proteins was through their
T7-epitope. As evident from Figure 5a, previously identiﬁed
interactors were co-immunoprecipitated with Sox10 from
extracts in which both were co-expressed, including the
zinc ﬁnger protein Krox-20, the homeodomain protein Dlx5
Figure 3. Interaction of the Sox HMG domain with DNA-binding domains of
many other transcription factors in GST pulldown experiments. DNA-binding
domains of additional transcription factors which are co-expressed with SoxE
proteins in vivo were tagged with a T7 epitope, expressed in HEK 293 cells
and analyzed for their ability to interact with GST or the GST-Sox10A,
GST-Sox10B,GST-Sox8A,GST-Sox8B,GST-SRYAandGST-SRYBfusions
(see Figure 2a). Analyzed DNA-binding domains include: bHLH domain
(REB, Olig2), bZip domain (c-Jun, C/EBPa), C2H2 zinc finger (Krox-20,
Sp1), C4 zinc finger (estrogen receptor ER, thyroid hormone receptor
T3Rb), paired domain (Pax3) and POU-specific domain (Oct-3/4). The
amountofeachDNA-bindingdomainpresentinone-tenthoftheextractbefore
pulldown (1/10 input) is shown in the right lane of each panel. DNA-binding
domains were detected on western blots via their T7 epitope tag.
Nucleic Acids Research, 2006, Vol. 34, No. 6 1739and the bZip proteins C/EBPa and c-Jun. When Sox10 was
exchanged by Sox8, co-immunoprecipitation was still
observed thus conﬁrming that Sox8 is as much an interaction
partner as Sox10 (Figure 5b). In the reciprocal experiment,
SoxE proteins were also co-immunoprecipitated with these
transcription factors as evidenced from the presence of
Sox10 in Olig2 immunoprecipitates (Figure 5c). However,
only a small percentage of the interaction partner was detec-
ted in the immunoprecipitates, suggesting a fairly weak
interaction between both proteins. The assumption of a
weak interaction was also supported by two other observa-
tions. Already moderate increases in the salt concentration
from 100 to 150 mM NaCl led to strong reductions in the
amount of co-precipitated or pulled-down partner protein
(data not shown). Additionally, interactions were not stable
under electrophoretic mobility shift conditions. No changes in
complex formation between Sox10 and its binding sites were
observed in the presence of increasing amounts of its inter-
action partners. In particular, no ternary complex formed that
contained the interaction partner in addition to Sox10 and its
binding site (data not shown).
Despite their weakness, interactions strongly inﬂuenced
promoter activities in reporter gene assays. A promoter that
contained multiple AP1-binding sites, but no Sox binding
site was efﬁciently activated by c-Jun only as long as
Sox10 was absent. Co-transfection of even sub-stoichiometric
amounts of Sox10 or Sox8 expression plasmid efﬁciently
abolished c-Jun-dependent reporter gene activation
(Figure 6a and data not shown). In contrast, regulatory regions
with binding sites for both Sox protein and its interaction
partners were cooperatively activated as shown for the
Schwann-cell speciﬁc enhancer of the Krox-20 gene
(Figure 6b), which is jointly activated by Sox10 and Brn-2
or Oct-6 in Schwann cells (15). Interestingly, Sox8 cooperated
as efﬁciently with Brn-2 in activating this enhancer as Sox10
(Figure 6b). Sox8 also activated the Connexin-32 promoter
in cooperation with Krox-20 (data not shown) as previously
shown for Sox10 (14).
Interaction requires specific contacts with the
C-terminal tail of the SoxE HMG domain
Previous studies on the POU protein Oct-3/4 and Sox2 had
identiﬁed interactions between the POU-speciﬁc DNA-
binding domain and the HMG domain under conditions
where both proteins were bound to DNA on adjacent binding
sites (29). Depending on the exact spacing and orientation of
binding sites and therefore depending on the relative orienta-
tion of POU and HMG domains, interactions were disrupted
by amino acid substitutions in helix 3 (R100E and M104E) or
in the C-terminal tail of the HMG domain (R115E).
To analyze whether the same residues were also involved
in the interaction of the SoxE HMG domain with other
DNA-binding domains in solution, the corresponding muta-
tions were introduced into the C-terminal tail of the Sox10
HMG domain (R176E, m1 mutant in Figure 7) or into
helix 3 (R161E and K165E, m2 mutant in Figure 7). When
pulldown assays were performed with GST fusion proteins
carrying the C-terminal part of the Sox10 HMG domain in
the m1 mutant version, no interactions were observed with
any of the bZip, bHLH, zinc ﬁnger or homeodomains
(Figure 7). In contrast, mutant m2 interacted as efﬁciently
with these DNA-binding domains as the wild-type. The
same pattern was also observed in pulldown experiments
with the POU-speciﬁc domain of Oct-3/4 arguing that the
Figure 4. Interaction of other HMG domains with DNA-binding domains of
transcription factors in GST pulldown experiments. (a) Schematic representa-
tion of UBF1, HMGB1 and LEF-1 with their HMG domains and GST fusion
proteins GST-U3, GST-U6, GST-H2 and GST-L1. Numbers above bars repre-
sent amino acids at the beginning or end of proteins, domains and protein
fragments. (b) T7-tagged DNA-binding regions from several transcription
factors (Olig2, C/EBPa, Krox-20, Pax3 and Dlx5) were expressed in HEK
293 cells and analyzed for their ability to interact with GST or the GST fusions
with HMG domains from UBF1 (U3, U6), HMGB1 (H2) and LEF-1 (L1).
DNase I waspresentthroughoutthe experiment. Theamountof eachtranscrip-
tion factor present in one-tenth of the extract before pulldown (1/10 input)
is shown in the right lane of each panel. Transcription factor fragments were
detected on western blots via their T7 epitope tag.
1740 Nucleic Acids Research, 2006, Vol. 34, No. 6C-terminal tail of the HMG domain is generally essential
for protein–protein interactions in solution. In contrast,
the previously observed interaction with helix 3 of the
HMG domain appears restricted in its importance to the inter-
action between Sox2 and Oct-3/4 or to protein interactions
on DNA.
DISCUSSION
So far the HMG domain of Sox proteins has been primarily
perceived as a DNA-binding and DNA-bending domain
(4,38). In agreement with previous ﬁndings (16,39,40), we
show in this manuscript that the HMG domain also ﬁgures
Figure 5. Confirmation of transcription factor interactions in co-immunoprecipitation experiments. (a and b) DNA-binding domains of several transcription
factors (Dlx5, C/EBPa, c-Jun and Krox-20) were expressed in HEK293 cells in the presence or absence of myc-tagged Sox10 (amino acids 1–203) (a) or Sox8
(amino acids 1–175) (b) and precipitated from extracts by antibodies against the myc tag. Following immunoprecipitation (IP), transcription factors were
detected in the precipitates on western blots with an antiserum directed against their T7 epitope. The presence of myc-tagged Sox10, myc-tagged Sox8 (myc)
and T7-tagged transcription factors (T7) in the extract is indicated above each lane. The amount of each transcription factor present in one-tenth of the extract
beforeprecipitation(1/10input)isshownintherighthalf.(c),FulllengthSox10wasexpressedinHEK293cellsinthepresenceorabsenceofmyc-taggedOlig2and
precipitatedfromextractsbyantibodiesagainstthemyctag.FollowingIP,Sox10wasdetectedin theprecipitatesonwesternblotswithaSox10-specific antiserum.
The presence of myc-tagged Olig2 (myc) and Sox10 in the extract is indicated above each lane. The amount of Sox10 present in one-tenth of the extract before
precipitation (1/10 input) is shown in the right half.
Figure 6. GeneexpressioninthepresenceofSoxproteinsandtheirinteractionpartners.ReportergeneassayswereperformedastransienttransfectionsinS16cells.
(a) A luciferase reporter with multimerized AP1-binding sites and minimal promoter (TRE-luc) was transfected alone or with c-Jun in the absence or presence of
increasing amounts of Sox10 (one-tenth the amount of c-Jun and equal amounts) as indicated. (b) A luciferase reporter consisting of the Schwann-cell specific
enhancerofthe mouseKrox-20gene(15)andminimalpromoter(SCE-luc)wastransfectedaloneorwithexpressionplasmidsforSox10,Sox8andBrn-2in various
combinations as indicated. Activation rates for each promoter are presented as fold inductions ± SEM. Luciferase activities were determined in two experiments
each performed in duplicates.
Nucleic Acids Research, 2006, Vol. 34, No. 6 1741prominently as a protein–protein interaction domain that
establishes contacts with a wide variety of DNA-binding
domains found in many other transcription factors. This
additional feature of the HMG domain may prove equally
important for the architectural function of Sox proteins on
gene regulatory sequences.
Protein–protein interactions were mediated by the
C-terminal part of the HMG domain which includes helix 3
and the C-terminal tail region (29,30). Conspicuously, both
regions are not involved in establishing DNA contacts
indicating that they are still available for interactions with
other proteins after Sox proteins bind to DNA. In particular,
the C-terminal tail region which is unstructured in solution is a
good candidate for these interactions. This was experimentally
supported by the disruption of all interactions by the m1 muta-
tion in which an arginine residue in the C-terminal tail region
was substituted by a glutamate. The C-terminal tail region
is furthermore speciﬁc to the HMG domain of Sox proteins
and is not found in other HMG domains. Accordingly, no
interactions were observed with the HMG domains of
LEF-1, HMGB1 or UBF-1.
The fact that the HMG domain of Sox proteins interacts
quite promiscuously with many different DNA-binding
domains may explain why different Sox proteins exhibit
at least partial redundancy in tissues where they are
co-expressed, such as Sox8 and Sox9 in the developing testis
and spinal cord, or Sox8 and Sox10 in oligodendrocytes or
the developing enteric nervous system (6–8,41). It also argues
that each Sox protein should be able to accept different
transcription factors as interaction partners in different tissues
or at different stages of development in a particular cell type.
Accordingly, Sox10 is known to team up with Pax3 in neural
crest-derived precursor cells, with Krox-20 in Schwann cells
of the peripheral nervous system and with Mitf in melanocytes
(13,14,16–18). This ﬂexibility in the choice of interaction
partners could be one of the reasons for the pleiotropic
functions of Sox proteins.
Unfortunately, our results do not yield clues for the origin of
speciﬁcity in the interaction between Sox proteins and its
partners in vivo. Thus it needs to be clariﬁed how promiscuous
protein–protein interaction in solution is turned into speciﬁc
functional cooperativity on target genes. It is important
to stress that the contacts between HMG domain and DNA-
binding domains of other transcription factors are fairly weak.
Weak interactions are easily reversible and will allow the
HMG domain to constantly change interaction partners in
solution. It is likely that this weak protein–protein interaction
has to be additionally strengthened to translate into functional
consequences. This may be partially achieved through regions
outside the DNA-binding domain of both the Sox protein and
the partner transcription factor. Additionally, reinforcement
may occur when the Sox protein and its partner transcription
factor both bind to the same regulatory sequence. In the sim-
plest case, physical contact between the DNA-binding
domains of a Sox protein and its transcriptional partner
may elicitcooperativebindingofbothproteins.This,however,
requires that the binding sites for Sox protein and transcrip-
tional partner are closely spaced in a composite recognition
element (4). Such composite elements have indeed been
identiﬁed in several gene regulatory sequences
(16,19,39,40,42,43). For Sox10, only one composite element
has been described in the c-Ret enhancer which is coopera-
tively bound and synergistically activated by Sox10 and Pax3
(16). Quite interestingly and in agreement with our ﬁndings,
synergistic activation of the c-Ret enhancer required direct
interaction of the paired domain of Pax3 with the HMG
domain of Sox10 (16). However, other promoters which are
synergistically activated by Sox10 and its partners do not
exhibit this arrangement of binding sites in a composite
element. This includes the Mitf promoter which is known to
be synergistically activated by Sox10 and Pax3 (13,18), the
Dct promoter which is synergistically activated by Sox10 and
Mitf (17), the Schwann-cell speciﬁc enhancer of the Krox-20
gene which is activated by Sox10 and Brn-2 or Oct-6 (15), and
the Connexin-32 promoter which is jointly activated by
Sox10 and Krox-20 (14). Whether physical contacts between
HMG domain and DNA-binding domain of partner transcrip-
tion factor are only important on regulatory sequences with
composite elements or also on those regulatory sequences that
contain separate binding sites for SoxE proteins and their
transcriptional partner proteins in greater distance, remains
to be seen. Our attempts at resolving this issue by analyzing
Figure 7. Mappinginteractionsto the C-terminal tail regionof the SoxE HMG
domain in GST pulldown experiments. DNA-binding domains of transcrip-
tion factors Dlx5, UTF1, Olig2, c-Jun, C/EBPa, Krox-20 and Oct-3/4 were
expressedinHEK293cellsandanalyzedfortheirabilitytointeractwithGSTor
theGST-Sox10Bfusioncarryingaminoacids133–203ofSox10.GST-Sox10B
was generated in a wild-type version (wt) and in mutant versions that either
carried the R176E substitution (m1) or the R161E, K165E double mutation
(m2).Theamountofeachtranscriptionfactorpresentinone-tenthoftheextract
before pulldown (1/10 input) is shown in the right lane of each panel.
Transcription factors were detected on western blots via their T7 tag.
1742 Nucleic Acids Research, 2006, Vol. 34, No. 6the transcriptional activity of the Sox10 m1 mutant on various
Sox10-dependent regulatory sequences failed, because the m1
mutation (and alternative substitutions of R176 by alanine or
lysine, data not shown) not only abolished interactions with
other DNA-binding domains in solution but also disrupted one
of the two nuclear localization signals (44) and therefore inter-
fered with efﬁcient translocation into the nucleus (data not
shown).
Whatever the exact mechanism, our ﬁnding of numerous
interactions with DNA-binding domains of other transcription
factors throws new light on to the HMG domain of Sox
proteins. It may help to understand the pleiotropic nature of
Sox protein function and functional equivalency among Sox
proteins.
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